Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 4/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13006675 | 0.91 | USP2 (0.38) | USP2MEN1KMT2AKDM4E | |
| SCHEMBL9913178 | 0.89 | USP2 (0.37) | USP2MEN1KMT2AKDM4E | |
| SCHEMBL11954167 | 0.89 | LPAR5 (0.32) | USP2CYP3A4LPAR5CYP1A2CYP2C19 | |
| SCHEMBL16852332 | 0.86 | TSHR (0.41) | ALDH1A1LPAR5 | |
| SCHEMBL331864 | 0.86 | TSHR (0.41) | ALDH1A1LPAR5 | |
| SCHEMBL18176161 | 0.85 | TSHR (0.40) | ALDH1A1LPAR5 | |
| SCHEMBL12889087 | 0.85 | USP2 (0.35) | USP2ALDH1A1CYP3A4MAPTHPGD | |
| SCHEMBL410909 | 0.83 | TSHR (0.41) | ALDH1A1CYP3A4HPGDTP53LPAR5 | |
| SCHEMBL13967786 | 0.83 | USP2 (0.30) | USP2 | |
| SCHEMBL27273321 | 0.82 | USP2 (0.42) | USP2CYP3A4LPAR5CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 251 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12638613-B2 | Ophthalmic lenses and their manufacture by in-mold modification | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2026-05-26 | — | — | US | disclosed |
| EP-4408852-B1 | ANTHRAQUINONE-FUNCTIONALIZED POLYMERIZATION INITIATORS AND THEIR USE IN THE MANUFACTURE OF OPHTHALMIC LENSES | JOHNSON & JOHNSON VISION CARE (US) | 2026-04-08 | — | — | EP | disclosed |
| US-12595370-B2 | Polymerizable absorbers of UV and high energy visible light | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2026-04-07 | — | — | US | disclosed |
| US-12595371-B2 | Contact lens with improved vision break-up time | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2026-04-07 | — | — | US | disclosed |
| US-20260070882-A1 | PHOTOSTABLE MIMICS OF MACULAR PIGMENT | JOHNSON & JOHNSON VISION CARE (US) | 2026-03-12 | — | — | US | disclosed |
| EP-4707342-A2 | CONTACT LENS DISPLAYING IMPROVED VISION ATTRIBUTES | Johnson & Johnson Vision Care, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| US-20260062386-A1 | POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT | JOHNSON & JOHNSON VISION CARE (US) | 2026-03-05 | — | — | US | disclosed |
| EP-4408899-B9 | AMIDE-FUNCTIONALIZED POLYMERIZATION INITIATORS AND THEIR USE IN THE MANUFACTURE OF OPHTHALMIC LENSES | JOHNSON & JOHNSON VISION CARE (US) | 2026-02-18 | — | — | EP | disclosed |
| EP-4165465-B1 | SYSTEMS AND METHODS FOR INDICATING THE TIME ELAPSED SINCE THE OCCURRENCE OF A TRIGGERING EVENT | JOHNSON & JOHNSON VISION CARE (US) | 2026-02-18 | — | — | EP | disclosed |
| US-20260043940-A1 | N-VINYL OXAZOLIDINONE MONOMERS, POLYMERS THEREFROM, AND USE IN OPHTHALMIC DEVICES | JOHNSON & JOHNSON VISION CARE (US) | 2026-02-12 | — | — | US | disclosed |
| EP-2566911-A1 | NON-REACTIVE, HYDROPHILIC POLYMERS HAVING TERMINAL SILOXANES AND USES OF THE SAME | Johnson & Johnson Vision Care, Inc. (US) | 2013-03-13 | — | — | EP | disclosed |
| US-8222353-B2 | Wettable hydrogels comprising acyclic polyamides | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2012-07-17 | — | — | US | disclosed |
| US-20110294914-A1 | WETTABLE HYDROGELS COMPRISING ACYCLIC POLYAMIDES | JOHNSON & JOHNSON VISION CARE, INC. | 2011-12-01 | — | — | US | disclosed |
| WO-2011140318-A1 | NON-REACTIVE, HYDROPHILIC POLYMERS HAVING TERMINAL SILOXANES AND USES OF THE SAME | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2011-11-10 | — | — | WO | disclosed |
| US-20110275734-A1 | NON-REACTIVE, HYDROPHILIC POLYMERS HAVING TERMINAL SILOXANES AND METHODS FOR MAKING AND USING THE SAME | JOHNSON & JOHNSON VISION CARE, INC. | 2011-11-10 | — | — | US | disclosed |
| US-8022158-B2 | Wettable hydrogels comprising acyclic polyamides | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2011-09-20 | — | — | US | disclosed |
| US-7786185-B2 | Wettable hydrogels comprising acyclic polyamides | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2010-08-31 | — | — | US | disclosed |
| US-20100151123-A1 | WETTABLE HYDROGELS COMPRISING ACYCLIC POLYAMIDES | JOHNSON & JOHNSON VISION CARE, INC. | 2010-06-17 | — | — | US | disclosed |
| EP-1720943-B1 | WETTABLE HYDROGELS COMPRISING ACYCLIC POLYAMIDES | JOHNSON & JOHNSON VISION CARE (US) | 2009-02-11 | — | — | EP | disclosed |
| US-20080045612-A1 | Wettable hydrogels comprising acyclic polyamides | JOHNSON & JOHNSON VISION CARE, INC | 2008-02-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100151123-A1 | WETTABLE HYDROGELS COMPRISING ACYCLIC POLYAMIDES | CRYAA, UACA, CRYZ | USP2 360/4885ALDH1A1 4436/4885CYP3A4 4533/4885 |
| US-12595370-B2 | Polymerizable absorbers of UV and high energy visible light | NLRP3, NLRP1, XDH | USP2 819/4885ALDH1A1 738/4885CYP3A4 19/4885 |
| US-20260062386-A1 | POLYMERIZABLE FUSED TRICYCLIC COMPOUNDS AS ABSORBERS OF UV AND VISIBLE LIGHT | ERCC1, MCM6, GPR6 | USP2 3865/4885ALDH1A1 3065/4885CYP3A4 318/4885 |
| US-12595371-B2 | Contact lens with improved vision break-up time | CUTA, VEGFA, CASP14 | USP2 1719/4885ALDH1A1 3458/4885CYP3A4 325/4885 |
| US-12638613-B2 | Ophthalmic lenses and their manufacture by in-mold modification | UACA, AXL, CRYZ | USP2 1733/4885ALDH1A1 1768/4885CYP3A4 1323/4885 |
| US-20260070882-A1 | PHOTOSTABLE MIMICS OF MACULAR PIGMENT | CRY1, CRY2, XPA | USP2 4165/4885ALDH1A1 3685/4885CYP3A4 1582/4885 |
| US-20260043940-A1 | N-VINYL OXAZOLIDINONE MONOMERS, POLYMERS THEREFROM, AND USE IN OPHTHALMIC DEVICES | CARM1, HVCN1, OGFOD1 | USP2 955/4885ALDH1A1 455/4885CYP3A4 1625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.